+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Desmopressin - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • December 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302038

Quick Summary:

In a rapidly advancing world of pharmaceuticals, it is crucial to stay ahead with the most updated, informed, and strategic market trends. This is where our newly released extensive research report on the global Desmopressin market comes into play.

Our detailed report on the Desmopressin market, valued at $1.2 billion in 2022 and projected to reach $2 billion by 2030, presents crucial data-driven insights, growth trends, and projections that impact key sectors such as Injectable Solution and Nasal Spray. Furthermore, it offers an in-depth analysis of the U.S and China—the two significant players in the market. Geographical trends, as well as notable markets like Japan, Canada, and Europe are also covered to give a comprehensive understanding of the market dynamics.

Moreover, the report offers updated competitors' data with a special focus on market shares and geographical presence. To facilitate user collaboration and provide additional value, we also offer interactive peer-to-peer updates, access to our digital archives and Research Platform; with complimentary updates for one year. Make the smart decision and equip your strategy with our state-of-the-art market insights today.

Global Desmopressin Market to Reach $2 Billion by 2030

The global market for Desmopressin estimated at US$1.2 Billion in the year 2022, is projected to reach a revised size of US$2 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2022-2030. Injectable Solution, one of the segments analyzed in the report, is projected to record 7% CAGR and reach US$866.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Nasal Spray segment is readjusted to a revised 5.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $332.9 Million, While China is Forecast to Grow at 10.3% CAGR

The Desmopressin market in the U.S. is estimated at US$332.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$450.7 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 5.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Select Competitors (Total 42 Featured) -

  • Amring Pharmaceuticals, Inc.
  • Avenit AG
  • Bachem
  • BP PharmacueticalsLaboratories Company
  • Ferring B.V
  • Amring Pharmaceuticals, Inc.
  • Northstar Rx LLC
  • Pfizer, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Desmopressin

What is the estimated value of the Global Market for Desmopressin?

The Global Market for Desmopressin was estimated to be valued at $1.2 Billion in 2022.

What is the growth rate of the Global Market for Desmopressin?

The growth rate of the Global Market for Desmopressin is 6.6%, with an estimated value of $2 Billion by 2030.

What is the forecasted size of the Global Market for Desmopressin?

The Global Market for Desmopressin is estimated to be worth $2 Billion by 2030.

Who are the key companies in the Global Market for Desmopressin?

Key companies in the Global Market for Desmopressin include Amring Pharmaceuticals, Inc., Avenit AG, Bachem, BP PharmacueticalsLaboratories Company, Ferring B.V, Amring Pharmaceuticals, Inc., Northstar Rx LLC, Pfizer, Inc., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceuticals Industries Ltd..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Desmopressin - Global Key Competitors Percentage Market Share in 2021 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2021 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Desmopressin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Desmopressin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Desmopressin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for InjecTable Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for InjecTable Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for InjecTable Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Nasal Spray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Nasal Spray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Nasal Spray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Tablet by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Tablet by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Tablet by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Desmopressin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 15: USA Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 16: USA 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 18: Canada Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: Canada 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
JAPAN
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: Japan Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: Japan 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
CHINA
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: China Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: China 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
EUROPE
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Desmopressin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Desmopressin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: Europe 16-Year Perspective for Desmopressin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 29: Europe Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: Europe 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
FRANCE
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: France Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: France 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
GERMANY
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Germany Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Germany 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Italy Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: Italy 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: UK Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: UK 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
SPAIN
  • Table 44: Spain Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: Spain Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Spain 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
RUSSIA
  • Table 47: Russia Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Russia Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Russia 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Rest of Europe Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Rest of Europe 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Desmopressin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Desmopressin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: Asia-Pacific 16-Year Perspective for Desmopressin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 58: Asia-Pacific 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
AUSTRALIA
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • Table 59: Australia Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: Australia Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 61: Australia 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
INDIA
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • Table 62: India Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: India Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 64: India 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
SOUTH KOREA
  • Table 65: South Korea Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: South Korea Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 67: South Korea 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
REST OF ASIA-PACIFIC
  • Table 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Rest of Asia-Pacific Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 70: Rest of Asia-Pacific 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
LATIN AMERICA
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • Table 71: Latin America Recent Past, Current & Future Analysis for Desmopressin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 72: Latin America Historic Review for Desmopressin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 73: Latin America 16-Year Perspective for Desmopressin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
  • Table 74: Latin America Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: Latin America Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 76: Latin America 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
ARGENTINA
  • Table 77: Argentina Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: Argentina Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 79: Argentina 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
BRAZIL
  • Table 80: Brazil Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Brazil Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 82: Brazil 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
MEXICO
  • Table 83: Mexico Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Mexico Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 85: Mexico 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
REST OF LATIN AMERICA
  • Table 86: Rest of Latin America Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Rest of Latin America Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 88: Rest of Latin America 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
MIDDLE EAST
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • Table 89: Middle East Recent Past, Current & Future Analysis for Desmopressin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 90: Middle East Historic Review for Desmopressin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 91: Middle East 16-Year Perspective for Desmopressin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
  • Table 92: Middle East Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Middle East Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 94: Middle East 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
IRAN
  • Table 95: Iran Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 96: Iran Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 97: Iran 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
ISRAEL
  • Table 98: Israel Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 99: Israel Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 100: Israel 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
SAUDI ARABIA
  • Table 101: Saudi Arabia Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 102: Saudi Arabia Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 103: Saudi Arabia 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
UNITED ARAB EMIRATES
  • Table 104: UAE Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 105: UAE Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 106: UAE 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
REST OF MIDDLE EAST
  • Table 107: Rest of Middle East Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 108: Rest of Middle East Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 109: Rest of Middle East 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
AFRICA
  • Desmopressin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
  • Table 110: Africa Recent Past, Current & Future Analysis for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 111: Africa Historic Review for Desmopressin by Form - InjecTable Solution, Nasal Spray and Tablet Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 112: Africa 16-Year Perspective for Desmopressin by Form - Percentage Breakdown of Value Sales for InjecTable Solution, Nasal Spray and Tablet for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Amring Pharmaceuticals, Inc.
  • Avenit AG
  • Bachem
  • BP PharmacueticalsLaboratories Company
  • Ferring B.V
  • Amring Pharmaceuticals, Inc.
  • Northstar Rx LLC
  • Pfizer, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd.